GOLDMAN SACHS GROUP INC - CALADRIUS BIOSCIENCES INC ownership

CALADRIUS BIOSCIENCES INC's ticker is CLBS and the CUSIP is 128058104. A total of 39 filers reported holding CALADRIUS BIOSCIENCES INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of CALADRIUS BIOSCIENCES INC
ValueSharesWeighting
Q2 2016$24,000
+4.3%
41,274
+36.5%
0.00%
Q1 2016$23,000
-30.3%
30,239
-0.7%
0.00%
Q4 2015$33,000
-40.0%
30,444
-18.1%
0.00%
Q3 2015$55,000
-73.3%
37,150
-66.2%
0.00%
Q2 2015$206,000109,9150.00%
Other shareholders
CALADRIUS BIOSCIENCES INC shareholders Q2 2016
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,248,781$3,351,0001.32%
Knoll Capital Management, LLC 1,000,000$1,490,0000.63%
TWO SIGMA SECURITIES, LLC 17,421$26,0000.04%
HighPoint Advisor Group LLC 14,631$22,0000.02%
SCHMIDT P J INVESTMENT MANAGEMENT INC 12,199$18,0000.01%
VANGUARD GROUP INC 6,941,076$173,083,0000.01%
Integrated Wealth Management 3,900$6,0000.00%
Cetera Advisors LLC 15,600$23,0000.00%
Joel Isaacson & Co., LLC 1,600$2,0000.00%
SIMPLEX TRADING, LLC 5,000$7,0000.00%
View complete list of CALADRIUS BIOSCIENCES INC shareholders